477 related articles for article (PubMed ID: 19199892)
1. Diabetic retinopathy and angiogenesis.
Crawford TN; Alfaro DV; Kerrison JB; Jablon EP
Curr Diabetes Rev; 2009 Feb; 5(1):8-13. PubMed ID: 19199892
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
Simó R; Carrasco E; García-Ramírez M; Hernández C
Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
[TBL] [Abstract][Full Text] [Related]
3. Novel role of erythropoietin in proliferative diabetic retinopathy.
Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
[TBL] [Abstract][Full Text] [Related]
7. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
8. [Aging and retinal vascular diseases].
Takagi H
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
[TBL] [Abstract][Full Text] [Related]
9. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy.
Behl T; Kotwani A
Pharmacol Res; 2015 Sep; 99():137-48. PubMed ID: 26054568
[TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy.
Wong TY; Cheung CM; Larsen M; Sharma S; Simó R
Nat Rev Dis Primers; 2016 Mar; 2():16012. PubMed ID: 27159554
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
12. [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].
Valiatti FB; Crispim D; Benfica C; Valiatti BB; Kramer CK; Canani LH
Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):106-13. PubMed ID: 21584427
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of angiogenic inhibitors: a potential pathogenic mechanism for diabetic complications.
Ma JX; Zhang SX; Wang JJ
Curr Diabetes Rev; 2005 May; 1(2):183-96. PubMed ID: 18220594
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
16. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27918469
[TBL] [Abstract][Full Text] [Related]
17. [Role of VEGF in diseases of the retina].
Barquet LA
Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():3-5. PubMed ID: 25925044
[TBL] [Abstract][Full Text] [Related]
18. Novel targets against retinal angiogenesis in diabetic retinopathy.
Wang S; Park JK; Duh EJ
Curr Diab Rep; 2012 Aug; 12(4):355-63. PubMed ID: 22638940
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.
Wilkinson-Berka JL
Curr Pharm Des; 2004; 10(27):3331-48. PubMed ID: 15544519
[TBL] [Abstract][Full Text] [Related]
20. Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis.
Aouiss A; Anka Idrissi D; Kabine M; Zaid Y
Curr Res Transl Med; 2019 May; 67(2):62-71. PubMed ID: 30685380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
